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Plant-Derived Anti-Malarial Agents: In vitro Inhibition of 
Hemozoin Synthesis by Extracts of Salvia Palaestina 
 
Abstract 
 
Malaria is an infectious disease that has drawn worldwide attention due to the alarming rise of 
mortality rates particularly in developing countries, where young children and pregnant 
women are at higher risk. The malaria parasite is a multi-stage one celled organism, called 
Plasmodium, which has co-evolved in mosquitoes and vertebrates for millions of years. The 
most common and lethal type of malaria infection is caused by Plasmodium falciparum. 
According to world malaria report and the latest WHO estimates, there were more than 219 
million cases of malaria in 2010 and an estimated 660, 000 deaths, where Africa is the most 
affected continent. Designing drugs that substantially and persistently interrupt the life cycle 
of this complex parasite will require a comprehensive understanding of its biology.  
The major concern in the treatment of malaria at present is the increasing resistance of the 
malaria parasite P. falciparum to anti-malarial drugs, particularly chloroquine, and this 
situation has been intensified by the increasing spread of drug-resistant P. falciparum strains. 
There are many targets in the fight against this dreadful disease, but our target is the intra-
erythrocytic stage in the parasite’s life cycle, during this stage, Plasmodium parasites reside 
inside the host erythrocytes degrading hemoglobin resulting in the accumulation of free heme; 
Ferriprotoporphyrin (IX), toxic to the parasite that is capable of generating oxygen radicals. 
The detoxification of the heme is through its incorporation into an insoluble crystal called 
hemozoin or malaria pigment. 
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 β-Hematin, a synthetic polymer made from Ferriprotoporphyrin- IX is structurally, 
chemically and spectroscopically identical to purified hemozoin, a polymer for in vitro studies 
in anti-malarial drug research. 
Natural products have played a key role in the discovery of leads for the development of 
drugs for malaria. Quinine, the original natural product used in anti-malarial therapy was 
isolated from Cinchona tree bark. 
This investigation aims to explore the activity of Palestinian herb (Salvia palaestina) 
(Maramia) as anti-malarial agent that prevents the formation of   β-hematin in vitro under 
specific chemical and physiochemical conditions. 
In this study the alcohol extracts of; salvia palaestina (Maramia) and Achillea Fragrantissima 
(Qaysom), were all screened for potential anti-malarial activity using a semi-quantitative in 
vitro method developed by E. Deharo. These plants were collected from areas around 
Jerusalem. Two other different sea weeds; Ulva fascianta and Cladophora aegagropila were 
all collected from Jaffa coast. Any tested plant extract with a positive result was also tested 
for their anti-malarial activity by a self-developed quantitative method. 
This investigation is the first report on the effect of Palestinian salvia palaestina extracts on 
the formation of the β–hematin. In this research it was found that salvia palaestina has the 
capability to impede the formation of β-hematin in in vitro systems. With very promising 
results, significant activity in inhibiting the formation of β-hematin in vitro at concentration of 
0.3 mg/ml when compared to the negative controls, water and 35% ethanol and the positive 
controls chloroquine, Amodiaquine and 2-mercaptopyrimidine. Sage has been an important 
medicinal plant since earliest times, with the most typical form of application as infusion with 
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boiling water (sage tea). It has value as a carminative, spasmolytic, antiseptic, astringent, and 
is used against variety of complaints, and now being tested for anti-malarial activity. 
Further investigations on the ability of salvia palaestina to inhibit β-hematin formation were 
performed using Blauer and Akkawi quantitative test which confirmed the previous results 
obtained, with β-hematin inhibition efficiency 71.7% compared to CQ 93% and negative 
control water 11%. 
Attempts were done to try to separate the active compound from the crude extract by using 
preparative chromatography coupled with photo diode array (PDA) detector, eight fractions 
were obtained. In order to identify which fraction has the anti-malarial activity, they were 
screened using E. Deharo semi-quantitative method. Moreover, combinations of the fractions 
were also tested. Different combinations of these fractions were also tested using the same 
method. 
Fourier Transform Infrared (FTIR) spectrum for the fractions was done as a first step in 
identification of the active ingredient. Further work is needed to identify the active 
compounds in salvia palaestina using Gas chromatography–mass spectrometry GC-MS, 
Nuclear magnetic resonance NMR and elemental analysis.  
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 ضد الملاريا: تثبيط بناء الهيموزوين في المختبر  كعواملنبات المشتقات 
 فيا بالستينالسا  الميرمية بواسطة مستخلصات من
 
 الملخص بالعربية:
  
 وفياتال معدلات في الخطير لارتفاعل نظرا عالميا اهتماما جذبت التي المعدية الأمراض أحد هو الملاريا
 . لهذا المرض عرضة كثررالا هم  الحوامل والنساء الصغار الأطفال حيث النامية، البلدان في خاصة
 البعوض في تطور لذيا ،البلازموديوم يدعى الخلية، أحادي حلامرال متعدد هو كثائن الملاريا طفيلو
هو البلازموديوم  الملاريا عدوى من وفتكا شيوعا الأكثرر النوعب يتسببالذي و. السنين لملايين والفقاريات
 الصحة منظمة تقديرات وأحدث العالمي الملاريا لتقرير فقاوو.   murapiclaf muidomsalPفالسباروم
 266 ،222 ب يقدر وما 2123 عام في بالملاريا إصابة حالة مليون 213 من أكثرر هناك كثان العالمية،
 حياة دورةأدوية  تقوم بشكل كثبير باعتراض  تصميم و .تضررا الأكثرر القارة هي أفريقيا حيث وفاة، حالة
 .الحيوية لوظائفه شاملا فهما تتطلب معقدال الطفيلي هذا
 فالسباروم الملاريا طفيل مقاومة تزايد هو الحاضر الوقت في الملاريا علاج في كبيرال قلقال مصدر
 بسببقد ازداد سوءا  الوضع هذا و ، eniuqorolhcينوالكلوروكث ولا سيما للملاريا، المضادة للأدوية
  .للأدوية المقاومة البلازموديوم فالسباروم سلالات انتشار تزايد
 كثريات داخل المرحلة هو هدفنا ولكن ،خطيرال المرض هذا مكافحة مجال في الأهداف من العديد هناك
 داخل تقيم لبلازموديوم ا طفيليات المرحلة، هذه خلال ففي الطفيل، هذا حياة دورة في اءالحمرالدم 
 الحر (الحديد)  الهيم تراكثم إلى يديؤ مما الحمراء للعائل  وتقوم  بتحليل الهيموغلوبين  الكريات
 إزالة . وتتمذرات أكثسجين نشطةسام للطفيل وقادر على توليد  فهو  , XI -niryhpropotorpirreF
 غةصب أو  niozomehهيموزوين يسمى للذوبان قابلة غير اتبلور في إدماجه خلال من الهيم يةسم
 .الملاريا
 9مركثب يدعى فيريبروتوبورفيريم من مصنع بوليمروهو  ،nitameh-β هيماتين-بيتا 
والذي يعتبرتركثيبه البنائي والكيماوي وتحليله الطيفي مطابق  )XI -niryhpropotorpirreF(
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 ةمضادال للادوية البحوث مجال في للدراسات المختبر في يتم استعماله البوليمر هذا النقي, هيموزوينلل
 .للملاريا
 أول ,الكينين. الملاريا لمكافحة عقاقير لتطوير ؤديت اتاكثتشاف في رئيسيا الطبيعية لعبت دورا المنتجات
 .الكينا شجرة لحاء من استخلاصه تم قد لملاريا،ا ضد العلاج في مستخدم صليأ طبيعي ناتج
كثمضاد   anitsealap aivlaSالفعالية للعشب الفلسطيني ( الميرمية)ويهدف هذا البحث لاستكشاف 
 للملاريا وقيامه بمنع تكوين البيتا هيماتين في المختبر تحت ظروف فيزيائية وكثيميائية.
 aellihcA والقيصوم  anitsealap aivlaSفي هذه الدراسة تم فحص المستخلص الكحولي للميرمية
واحتمالية فعاليتها كثمضاد للملاريا في المختبر باستخدام طريقة النصف كثمية التي   amissitnargarF
. وهذه النباتات تم جمعها من مناطق حول القدس. وهنالك عشبتين بحريتين أخرتين  oraheD .E وضعها
ي مستخلص نباتي وأتم جمعهما من ساحل يافا. aliporgagea arohpodalC و  atnaicsaf avlU
يعطي نتيجة ايجابية في الفحص يتم اختبار نشاطه كثمضاد للملاريا باستخدام طريقة كثمية تم بنائها ذاتيا 
 بالمختبر. 
تكوين  على   anitsealap aivlaSوهذا البحث هو الاول  الذي يبين  تاثير مستخلصات النبتة الفلسطينية 
تربيط تشكيل  لديها القدرة على anitsealap aivlaS ميرمية البيتا هيماتين, ففي هذا البحث وجد ان ال
مغ/مل  بالمقارنة مع الضوابط السلبية , الماء ومحلول كثحولي  2.2البيتا هيماتين في المختبر حتى تركثيز 
-2(و المركثبتو بايرمدين )QA(والامودياكثوين  )QC (% , والضوابط الايجابية الكلوروكثوين32بتركثيز 
من اهم النباتات الطبية منذ اقدم العصور, والطريقة الامرل لاستخدامها بواسطة نقعها  . الميرمية )PM
بالماء المغلي (شاي الميرمية). ولهذا الشاي قيمة بوصفها طارد للريح, مزيل للتشنجات, مطهر, قابض, 
 وتستعمل ضد مجموعة متنوعة من الامراض, والان يتم اختبار فعاليتها كثمضاد للملاريا.
عمل فحوصات إضافية بشأن قدرة الميرمية على منع تكوين البيتا هيماتين باستخدام الاختبار الكمي تم 
حصول عليها سابقا. بفعالية  في تربيط ال, التي اكثدت النتائج التي تم  iwakkAوعكاوي   reualBلبلور 
 %. 11% والماء كثضابط سلبي 39% مقارنة مع الكلوروكثوين 7.17البيتا هيماتين بقيمة 
مزود  الكروموتوغرافيا الفصل باستخدام الخام المستخلص من نشطال مركثبال لفصل تمحاولا تجر كثما
تم الحصول على ثمانية اجزاء. وبهدف التعرف على الجزء  ,)ADP( yarra edoid otohpبكاشف 
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, oraheD .Eالذي لديه فعالية ضد الملاريا, تم فحص الاجزاء باستخدام الطريقة النصف كثمية للعالم  
 .اضافة الى عمل تركثيبات مختلفة من هذة الاجزاء وفحصها باستعمال نفس الطريقة
طيف امتصاص التمت قراءة  ,المفصولة الأجزاء في ةالفعال اتكثخطوة اولى للتعرف على المكون
هنالك فحوصات اضافية بحاجة لعملها للتعرف على  ,)RITF(تحويلات فوريير للأشعة تحت الحمراءل
الرنين  , SM-CG الكتلي مع قياس الطيف يا الغازكثروموتوغرافالمادة  الفعالة في الميرمية باستخدام 
 .sisylana latnemele عنصريالتحليل وال  )RMN(المغناطيسي النووي 
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Abbreviations and Units: 
Table of abbreviations                                                              
Abbreviation      Full word 
FTIR   Fourier Transform Infrared spectroscopy 
DMSO   Dimethylsulfoxide 
ELISA Enzyme Linked Immuno Sorbent Assay 
Fe PPIX   Iron protoporphyrin IX 
UV  Ultra violet 
𝛌 Lambda 
ACN  Acetonitrile 
NaOH Sodium hydroxide 
EtOH   Ethanol 
PDA  Photo diode array detector 
P.  Plasmodium 
min Minute 
HPLC High Performance Liquid Chromatography 
S. palaestina   Salvia palaestina 
WHO   World Health Organization 
RBCs  Red blood cells 
CQ  Chloroquine 
AQ  Amodiaquine 
QN   Quinine 
QD  Quinidine 
MQ  Mefloquine 
2-MP 2-Mercaptopyrimidine 
ACT Artemisinin based Combination Therapy 
KBr Potassium bromide 
NMR  Nuclear magnetic resonance 
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Abbreviation      Full word 
GC-MS Gas chromatography–mass spectrometry 
β   Beta 
ODS octadecyl silane 
IC50 The half maximal inhibitory concentration 
F. Fraction 
 
List of Units:   
mg/ml: milligram per milliliter.  
M: Molar. 
µM: micro-molar. 
μL: microliter. 
m: micrometer. 
mm: millimeter.  
nm: nanometer.  
% : percent. 
wt. / vol : weight per volume.  
Rpm : Round per minute. 
ml/min: milliliter per minute. 
mbar: millibar. 
AU: absorption unit. 
˚C: degree centigrade. 
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Chapter 1 
Introduction 
 
Malaria is a mosquito borne parasitic disease of the blood caused by a Protozoan belonging to 
the genus Plasmodium which is widely distributed in many poor tropical and subtropical 
regions of the world. The disease is most prevalent in Africa, whose main victims are children 
under five years of age [WMR, 2012]. It is considered one of the major public health concerns 
globally where about 40% of the world’s population are currently at risk for malaria disease, 
in addition to killing thousands of poor people in developing countries each year; primarily 
African children because of the widespread drug resistance [White, 2004]. The complexity of 
malaria parasite mechanism together with the growing resistance to anti-malarial drugs 
presents several difficulties in the development of effective drugs against this disease. 
Besides, in poor areas where people are unable to afford and access effective anti-malarial 
drugs, traditional medicines could be an important source of treatment. 
 
This present work contributes to the fight against malaria by providing research on a new 
potential active compound from herbal origin. Species of the genus Salvia (Lamiaceae) are 
well known throughout the world for their medicinal properties which have made it an 
attractive choice for our research. 
 
According to [Knols, 2013] who wrote about Malaria in Palestine, that, Palestine was one of 
the malaria hopeless countries especially Jerusalem, Jaffa and Valley of Jordan termed 
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‘Soaked in Malaria’, see Figure 1.1 showing Huleh Lake in Palestine which was a breeding 
ground for malaria in the 50’s, and within 45 years Palestine was declared as ‘Malaria 
eradicated’ area. The steps that were taken to eradicate Malaria were based in eradicating the 
parasite carrier; data collection, education the population about the disease, drying streams 
and cleaning the pools where the parasite lives, the last step was the most important one in 
eliminating the parasite. 
 
 
Figure 1.1: Huleh Lake in Palestine, it was a breeding ground for malaria but drained in the 
1950s. 
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1. Literature Review   
1.1. The Disease: Malaria  
 
Malaria, one of the most important parasitic infections, it is even one of the oldest diseases 
known to mankind; recent studies showed that King Tutankhamun died of malaria [Hawass et 
al., 2010]. Malaria is caused by a one-celled parasite called Plasmodium [Bannister and 
Sherman, 2009], belonging to the parasitic phylum Apicomplexa. It is an entirely preventable 
and treatable disease but it is still a global health problem. According to the World Health 
Organization (WHO) and the World Malaria Report [WMR, 2012] an estimated 3.3 billion 
people were at risk of malaria in 2011, and about 219 million new cases arise per year making 
it the most prevalent serious infectious disease. More than 660, 000 people die from it, 91% of 
total malaria deaths occurred in the African Sub-Saharan region, a region well known of its 
high poverty rate and a major settlement for this parasitic disease. It presents a major disease 
hazard for travelers to warm climates [Snow et al., 2005]. Figure 1.2 shows the geographic 
distribution of malaria that is endemic in the tropics and subtropics, spreading in countries of 
Africa, Asia and Latin America. 
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Figure 1.2: Geological distribution of malaria around the world. 
After being infected with malaria by the female mosquito, symptoms usually begin within 10–
15 days, depending on the type of malaria. The clinical symptoms of malaria appear as a 
consequence of the parasite multiplication in the RBC, which are similar to the flu, such as: 
headache, fever, vomiting, muscular aching, weakness, vomiting and abdominal pain; it may 
therefore be commonly mistaken for flu. In more serious cases, infected red blood cells can 
clump together and block blood flow. At worst, the disease can damage internal organs, 
including the brain, and cause breathing difficulties, coma and death [Church et al., 1996; 
Beare et al., 2006; Clark et al., 2004]. 
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1.2. Malaria parasite: Plasmodium 
 
Plasmodium is a genus of unicellular parasitic protozoa which infect vertebrates and cause 
malaria. There are nearly 200 plasmodium species that are parasitic to mammals, birds, and 
reptiles. 
 
At present, only five major species commonly infect humans causing malaria; Plasmodium 
vivax, Plasmodium malariae, Plasmodium ovale, recently Plasmodium knowlesi [Cox-Singh 
et al., 2008] and the most dangerous Plasmodium falciparum [Bannister and Sherman, 2009]. 
All of these are transmitted to hosts solely through the bite of female Anopheles mosquito 
vector. Of these, P. falciparum causes the most severe disease and mortality as a result of its 
prevalence, virulence, and drug resistance, is responsible for the majority of malaria cases 
worldwide [Snow et al., 2005]. 
 
1.3. Plasmodium Life-cycle 
 
Plasmodium parasites have an elaborate lifecycle with multiple stages, which exhibit three 
lifecycle stages—gametocytes, sporozoites, and merozoites. The life cycle of the human 
malaria involves two hosts, firstly: the female anopheles mosquito, secondly: humans, see 
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Figure 1.4. Transmission of the parasite between the two hosts occurs only during the blood 
feeding of the mosquito vector, which needs blood to nurture its eggs [Levinson W., 2008]. 
 
Plasmodium species inhabit the salivary gland of the female anopheles mosquito in the form 
of sporozoites.  When a female anopheles mosquito with plasmodium bites humans, it 
transmits the sporozoites into the human body. Once in the blood, the sporozoites travel to the 
liver to invade the liver cells (hepatocyte), where the parasite undergoes an asexual replication 
forming merozoites, this stage is called the exo-erythrocytic stage, throughout this stage an 
infected person shows no signs or symptoms of the disease, and malaria cannot be detected in 
the routine microscopic examination of blood films. 
 
When Merozoits burst out of the liver cells, they journey back to the blood stream and infect 
healthy red blood cells. This stage of the infection is also called the intra-erythrocytic cycle. 
Inside red blood cells merozoits become enlarged ring shaped trophozoites, termed the ring 
stage due to its morphology in Geimsa-stained blood smears [Sherman, 1979], see Figure 1.3. 
Asexual replication occurs during the intra-erythrocytic stage releasing newly formed 
merozoites from the red blood cells, which in turn infect other RBC leading to massive 
destruction of RBC. When red blood cells destroyed by the merozoites liberate toxins, the 
continuous proliferation of malaria parasite inside the RBC’s is a distinct feature of malaria 
infection, and is chiefly responsible for the pathology of the disease [Pandey and Tekwani, 
1997], with each replication, some of the merozoites, instead of producing new merozoites, 
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develop into gametocytes, which can then infect susceptible mosquitoes, bringing the 
transmission cycle full circle. 
 
 
Figure 1.3: Ring-form trophozoites of P. falciparum in a blood smear. 
 
In turn, when an uninfected female mosquito bites an infected human the plasmodium 
gametophytes are taken, and after a series of divisions resulting in formation of active 
sporozoits which will inhabit the salivary gland of the mosquito waiting for its next victim. 
Thus the mosquito carries the disease from one human to another. Unlike the human host, the 
mosquito vector does not suffer from the presence of the parasites.  
Other transmission routes are possible, including blood transfusions [Slinger et al, 2001], 
congenital transmission from mother to fetus [Valecha et al. 2007], and through needle 
sharing. Understanding the complete lifecycle is important in understanding the pathogenicity 
of plasmodium parasite. 
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Figure 1.4: A diagram of the lifecycle of the plasmodium parasite showing the role of 
mosquito that is responsible for the spread of malaria. 
 
1.4. Hemozoin and β-hematin 
 
During the intra-erythrocytic stages the parasite consumes and degrades hemoglobin - iron 
containing metalloprotein and the major protein available in erythrocytes - as source of amino 
acids for its own nutrition, the digestion takes place inside the parasite’s food vacuole [Spiller 
et al., 2002; Klones et al., 2007] – an acidic proteolytic compartment – where the pH 5.0 - 5.4, 
with the aid of special type of enzymes called plasmepsins [Klemba et al.,2004; Liu et al., 
2005], it digests 60−80% of the available hemoglobin.  
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The byproduct of hemoglobin digestion is the release of large amounts of Iron protoporphyrin 
IX (FePPIX) in the ferrous form along with oxygen, causing its oxidation to the ferric form, 
or Ferri-heme which is highly reactive and toxic to the plasmodium [Egan, 2008; Sullivan, 
2000], these heme groups are able to induce oxidative stress that can damage the parasite 
biological membranes. It needs only about 0.1% of total hemoglobin present in RBC’s to be 
destroyed in order to produce enough free heme (20 mM) that can lyse malaria parasites 
within 10 minutes. However, malaria parasite has evolved a mechanism for detoxification of 
free heme through its mineralization [Slater et al., 1991] into an unreactive, insoluble 
crystalline form known as hemozoin or malaria pigment [Sullivan, 2000; Slater et al.,1991; 
Goldberg et al.,1990; Pagola et al.,2000; Egan et al., 2002; Tekwani and Walker 2005; Egan, 
2008]. Formation of hemozoin is crucial for parasite survival and has been the focus of many 
studies mainly because of its role in the pharmacological activity of several known anti-
malarials [Hawley et al., 1998]. 
 
β-hematin (FeIII-protoporphyrin-IX) is a synthetic analogue of purified hemozoin, 
constituting of cyclic heme dimers -where the central iron of one heme is linked to the oxygen 
of the carboxylate side chain of the adjacent heme- arranged  in an ordered crystalline 
structure through intermolecular hydrogen bonding [Slater el al.,1991; Gildenhuys et al., 
2012]. Figure 1.6 shows the structure free heme, β-hematin dimers and Hemozoin.  
β-Hematin is structurally, chemically and spectroscopically identical to purified hemozoin 
[Pagola et al.,2000], and can be produced in acidic solution and used in an assay to screen for 
anti-malarial compounds. 
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Figure 1.5: Presenting the structure free heme (A), the structure of β-hematin dimers (B), and 
structure of hemozoin, showing hydrogen bonds between hematin units as dotted 
blue lines, and coordinate bonds between iron atoms and carboxylate side chains 
as red lines  (C). 
 
1.5. Drugs Available for Treatment of Malaria 
 
Malaria may be cured with prescription drugs. The type of drugs and length of treatment 
depend on stage of parasite, which kind of malaria is diagnosed, where the patient was 
infected, age of the patient, and how severely ill the patient was at the beginning of the 
treatment. 
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     1.5.1. Quinoline Anti-malarial Drugs 
 
Quinoline anti-malarials originate from the compound quinine, which is an active anti-
malarial natural product found in the bark of Cinchona tree. The quinolone containing 
antimalarial drugs, such as chloroquine (CQ), amodiaquine (AQ), quinine (QN), quinidine 
(QD), and mefloquine (MQ) all have been vital therapeutic agents against malaria [Meshnick 
and Dobson,2001]. 
 
 
Figure 1.6: The chemical structure of main classes of anti-malarial drugs, chloroquine, 
primaquine, quinidine and quinine.  
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Chloroquine (4-aminoquinoline) the most common and effective drug used to treat malaria, its 
main advantage was its fast action against the blood stages, low toxicity, as well as its good 
bioavailability making it the ideal drug for Africa [krafts et al.,2012]. 
 
CQ targets the intra-erythrocytic stage particularly the hemozoin formation pathway, 
inhibition of heme detoxification of the malaria parasite leads to accumulation of toxic heme 
which in turn would kill the parasite [Hawley et al., 1998]. This is the mechanism of action of 
many known anti-malarials such as chloroquine, which accumulates inside the parasites food 
vacuole and forms heme-chloroquine complex that is incorporated into the growing hemozoin 
polymer to terminate chain extension [Gildenhuys et al., 2012] see Figure 1.7, resulting in the 
accumulation of free heme-chloroquine complex in the food vacuole, which is more potent to 
Plasmodium than free heme causing the parasite’s death [Sullivan et al., 1996; 1998]. 
 
 
Figure 1.7: A model showing chloroquine mode of action in inhibiting hemozoin formation. 
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1.5.2. Artemisinin and Its Derivatives 
 
Artemisinin is a powerful and the most effective anti-malaria drug, extractes from Artemisia 
annua, it is even effective against highly drug resistant plasmodium strains [Willcox et al., 
2004; Das, 2012], Chemically, artemisinin is a sesquiterpene lactone   containing an 
unusual peroxide bridge ,see Figure 1.8. This peroxide is believed to be responsible for the 
drug's mechanism of action. Semi-synthetic derivative Artemeter was found to be more active 
than its precursor and is the most frequently used artemisinin derivative as a first line 
treatment for malaria [Meshnick and Dobson, 2001]. 
 
Artemisinin, in the form of Artemisinin-based Combination Therapy (ACT), (combination of 
artemisinin and its derivatives with existing antimalarial drugs) is currently the best effective 
drug treatment option against those malaria parasites that have evolved resistance to drugs 
such as chloroquine, [Douglas et al.2010] for example; Artemisinin-Aminoquinoline hybrids 
showed good anti-malarial activity. 
 
Figure 1.8: Anti-malarial drug, Artemisinin chemical structure.  
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1.6. Anti-malarial Drug Resistance 
 
Malaria parasites are putting up a strong fight against anti-malarial drugs and recently have 
developed resistance against several drugs diminishing the therapeutic efficacy of drugs 
[Waller et al., 2003; Orjih et al., 1993; Reddy et al., 2012], which means the ability of a 
parasite species to survive and multiply despite the administration of a drug in doses equal to 
or higher than those usually recommended.  
 
Although CQ is still a safe, inexpensive and widely available drug, resistance to it now occurs 
across the tropical world, so it is no longer effective in many areas, see Figure 1.9. The 
genetic events that confer anti-malarial drug resistance are mutations in or changes in the 
copy number of genes encoding for influx/efflux pumps that affect intra-parasitic 
concentrations of the drug, for example; Chloroquine resistance in P. falciparum may be 
multi-genic and is initially conferred by mutations in a gene encoding a transporter (PfCRT) 
[Waller et al., 2003]. 
 
Resistance to anti-malarial drugs is proving to be a challenging problem in malaria control in 
most parts of the world. Since the early 60s the sensitivity of the parasites to CQ has been on 
the decline. This resistance began with P. falciparum and today is extremely common, 
especially in Africa, Newer anti-malarials have been developed in an effort to tackle this 
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problem [Agarwal et al., 2005; Aljazzar et al., 2010; Akkawi et al., 2012], but all these drugs 
are either expensive or have undesirable side effects. 
 
In recent years, artemisinin, has emerged as a new anti-malarial drug, and is being promoted 
as a new tool in the fight to eradicate the disease, though resistance is already reportedly 
spreading [Dondorp et al., 2009]. Although scientists worldwide are testing new malaria 
drugs, there are as yet no realistic alternatives to artemesinin combination drugs, which are 
considered the most effective. 
 
 
Figure1.9: World map showing the spread of anti-malarial drug resistance.  
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1.7. Natural Compounds as Anti-malarials 
 
Natural compounds were historically used as drugs. Plants have been used as a source of 
medicine throughout history and continue to serve as the basis for many pharmaceuticals used 
today as they can be found to be accessible and affordable. The history of anti-malarial drugs 
is intimately linked with the history of herbal medicinal products. For example, the bark of the 
Cinchona tree was one of the anti-fever herbs that led to the discovery of natural quinine (an 
alkaloid). In 1820 identified and isolated by the French scientists Pelletier and Caventou 
[Benedek T.], the first anti-malarial drug that is still used today as well as several synthetic 
quinolones, particularly chloroquine. 
 
Another example includes artemisinin, which is a terpene, the active ingredient of the Chinese 
herb, sweet wormwood (Artemisia annua) [Willcox et al., 2004; Das, 2012], which represents 
one of the great discoveries in medicine by Chinese scientists in 1972, and its derivatives have 
become essential components of anti-malarial treatment. This plant has been used as a 
traditional remedy for chills and fevers for more than 2000 years by the Chinese.  
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1.8. Salvia Palaestina: tea sage (Maramia): 
 
Salvia, the largest genus of the Lamiaceae family, includes about 900 species and is common 
throughout the world. Salvia palaestina is an important genus widely cultivated in Palestine 
Turkey, Syria, Iraq, Iran, and northeastern Egypt. This plant is an evergreen perennial herb 
that has been an important medicinal plant for centuries; and still used up to this day as herbal 
remedy. The Latin name Salvia comes from the Latin verb "salvare" meaning to save or to 
heal in reference to the curative properties of the plant. 
 
S. palaestina is an important domestic herbal remedy for disorders of the digestive system, 
also used in cooking and in the cosmetics industry. An infusion of dried sage leaves with 
boiling water is the most typical form of preparation, proven to be effective against many 
ailments [Duke et al., 2002]. 
 
The range of traditional applications of this herb in domestic medicine seems to be endless: it 
has been used as a medication against perspiration and fever; as a carminative; a spasmolytic; 
bactericidal; an astringent; as a gargle or mouthwash against the inflammation of the mouth, 
tongue and throat; a wound-healing agent; in skin and hair care; and against rheumatism and 
in treating mental and nervous conditions among others [Duke JA, 2001]. 
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Figure 1.10: leafs of Salvia palaestina, Maramia (sage tea) 
 
Previous studies showed that S. palaestina essential oils and extracts have excellent anti-
oxidant [Gürsoy et al., 2012], anti-bacterial [Karataş and Ertekin, 2010] and anti-proliferative 
[Fiore et al., 2006] properties.   
 
1.8.1 Secondary metabolites in Salvia species 
 
Plants in general constitute chemicals known as primary and secondary metabolites. Primary 
metabolites include compounds that are necessary for cellular processes such as amino acids, 
nucleic acids, lipids and simple sugars; whereas secondary metabolites are non-nutritional 
compounds which include compounds which are produced in response to stress factors on the 
plant or involved in cell metabolism [Kennedy and Wightman,2011]. Often, plant’s secondary 
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metabolites are considered to be an excellent reservoir of new medical compounds. There are 
two major groups of secondary metabolites terpenoids, phenolics. 
 
 Essential oil composition of Salvia species has previously been reported, the main secondary 
metabolite constituents are terpenoids [Cioffi et al., 2008; Vassallo et al., 2008] and 
flavonoids, also contain large amounts of thujone, [Gürsoy et al., 2012], which are considered 
potential anti-malarial agent. In addition, sage leaf contains numerous other compounds, 
including cineol, borneol, tannic acid; bitter substances like cornsole and cornsolic acid; 
fumaric, chlorogenic, caffeic and nicotinic acids; nicotinamide; flavones; flavone glycosides, 
thymol and camphor among many others [Gürsoy et al., 2012; Walch et al., 2011]. 
 
The largest class of plant secondary metabolites are alkaloids which are physiologically-active 
heterogeneous compounds containing nitrogen, and are one of the most important natural 
products, which offers drugs that exhibit anti-malarial activity, the outstanding example in 
this group is quinine [Oliveira et al.2009]. 
 
Terpenoids are derived from five-carbon isoprene units (C5H8) see Figure 1.11, classified by 
the number of isoprene units used to construct them. For example, monoterpenoids consist of 
two isoprene units, sesquiterpenoids (three units). Monoterpenoids and sesquiterpenoids are 
the primary components of essential oils, which are highly volatile compounds that contribute 
to the fragrance. 
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Figure 1.11: structure of isoperene unit. 
 
Flavonoids are one of the largest classes of phenolics, which are considered as ketone-
containing compounds, the basic structure of a flavonoid is shown in Figure 1.12. 
 
Figure 1.12: Structure of the flavone backbone. 
 
1.9 Achillea Fragrantissima (Qaysom):  
A member of compositae family that habitat dry areas, flowering time starts from May until 
August, see Figure 1.13, its antibacterial activity was studied by [Barel et al.,1991].this plant 
has been used in traditional medicine as disinfectant, gargle ,carminative, insect repellent and 
for chest complaints among many others. 
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Figure 1.13: Achillea Fragrantissima (Qaysom). 
 
1.10 Seaweeds as anti-malarials: 
Seaweeds are micro-algae that live in the sea. It includes members of the red, brown and 
green algae. They all have many uses in different as food, medicine, industrial and fertilizer. 
Recent studies on seaweeds from Fiji Island showed a compound called Bromophycolide A 
considered as antifungal agent, had the ability to prevent the formation of β-hematin [Stout et 
al., 2011]. 
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1.11 Purpose of this work: 
 
The main purposes of this study are: 
 To find a new potential anti-malaria drugs to target the hemozoin synthesis pathway 
during the intra-eryrthorcytic stage from natural sources. 
  
 To investigate the activity of water and ethanolic extracts of Salvia palaestina as 
potential anti-malarial agents. 
 
 To perform both in vitro semi-quantitative (E. Deharo, 2002) and quantitative method 
(Blauer and Akkawi, 1997) on the plant extracts to test β-hematin formation. 
 
 To develop a rapid analytical HPLC method that scans the active constituents from 
35% ehanolic crude salvia palaestina followed by enrichment and isolation of the 
active anti-malarial fractions by using preparative chromatography coupled with photo 
diode array (PDA) detector.   
 
 To retest the fractions obtained from the HPLC separation, in order to identify the 
fraction with anti-malarial activity.  
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Chapter 2 
Materials and Methods 
 
2.1. Instrumentation: 
 
 The analytical HPLC system consisted of Waters 2695 Alliance® equipped with 
2996 PDA model detector and Empower data software. The preparative HPLC 
consisted of 3535 quaternary gradient module which provide a flow rate of up to 
50 ml/min, equipped with 996 PDA detector. 
 Freeze Drying machine (Lyophilizer) from Labconco. 
 Rotary Evaporator from IKA WEREK RV06-ML. 
 Bench top pH meter from (WTW). 
 Analytical balance from Sartorius CP. 
 Water bath from Jouan. 
 Bench top B4- centrifuge from Jouan.   
 Stabili therm incubator from thermo. 
 Stat Fax-2100 ELISA reader. 
 Ultrasonic cleaner DC150H Sonicator 
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 Nicolet Avatar 370DTGS FTIR. 
 Carver compressor. 
 
2.2. Materials and chemicals: 
 
 DMSO, Dimethyl sulfoxide, purity 99.5% was obtained from Sigma Aldrich. 
 Chloroquine diphosphate salt was obtained from Sigma. 
 Hemin from porcine was obtained from Sigma. 
 Absolute Ethanol (EtOH) was obtained from Sigma Aldrich. 
 Glacial acetic acid was obtained from Fluka. 
 Sodium acetate. Purity 99% was obtained from Aldrich.  
 ACN, acetonitrile, HPLC grade, was purchased from Merck (Germany).  
 Highly Purified water was prepared by using a Millipore Milli-Q plus water 
purification system. 
 KBr, potassium bromide 99+%, FTIR grade was purchased from Sigma Aldrich. 
 Chloroform  
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2.3. Methods    
2.3.1 Plant collection: 
 
Salvia palaestina and Achillea Fragrantissima were collected from areas far from agricultural 
land around Jerusalem on Mach and December 2012 respectively, while the two different 
seaweeds Ulva fascianta, Cladophora aegagropila were collected from Jaffa coast on 
October 2012. Plant leafs were air dried in the shade. 
 
2.3.2 Extraction of the  plant samples:  
 
Leafs were grinded by electrical mixer into course powder. Extraction by the maceration 
method in 35% ethanol was carried out with the plant’s powder to solvent ratio 1:10 (wt./vol), 
the mixture was left for a period of 20-24 hours at room temperature without stirring. The 
extract was then filtered using MN615.Ø110 mm filter paper. The filtrate was then evaporated 
using rotary evaporator at 80˚C under reduced pressure. 
 
2.3.3 Lyophilization (Freeze Drying): 
Lyophilization is the process of isolating a solid substance from aqueous solution by freezing 
the solution and evaporating the ice under vacuum, it is carried out using a simple principle of 
physics called sublimation.  
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The extract, was frozen overnight then it was placed in the freeze dryer machine at temp -55 
°C and pressure 0.095 mbar, until a constant weight was achieved. The final dried extract was 
stored in bottles and kept in the freezer at -20 ˚C until use.  
 
2.3.4 In vitro screening for anti-malarial activity using  Semi-Quantitative 
Method: 
 
According to [Deharo et al., 2002], the procedure for testing bio-mineralization hemin 
consists of: 
1. Incubating a test mixture in a normal non-sterile flat bottom 96-well plate at 37 ºC for 
18-24 hours. 
            The mixture according to order of addition contained: 
           50 μL (0.5 mg/mL hemin chloride) freshly dissolved in dimethylsulphoxide (DMSO). 
           100 μL of 0.5 M sodium acetate buffer (pH 4.4) 
           and finally 50μL of potential anti-malarial drug solution or solvent. 
2. The plate was then centrifuged at 4000 rpm for 10 min. The supernatant was removed 
and pH of reaction was measured, the final pH between (5 - 5.2). 
3. The remaining pellets were then suspended in 200 μL of DMSO to remove free hemin 
chloride. 
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4. The plate was centrifuged again, the supernatant was discharged.  
5. The precipitate of β-hematin was dissolved in 150 μL of 0.1 M NaOH to give alkaline 
hematin for direct spectroscopic quantification at wavelength 405 nm using ELISA 
reader. 
* Salvia palaestina and Ulva fascianta extracts were dissolved in pure water, while Achillea 
Fragrantissima and Cladophora aegagropila extracts were dissolved in 35% ethanol, and 
camphor was dissolved in DMSO.  
*Ultra-pure water and 35% ethanol were used as negative controls and Chloroquine 
diphosphate salt, Amodiaquine and 2-mercaptopyrimidine as positive controls. 
 
2.3.5 Separation of the active anti-malarial fractions from crude Salvia 
palaestina by using reversed phase Preparative HPLC-PDA 
 
2.3.5.1 Chromatographic conditions:  
 
The HPLC analytical experiments were run on octadecyl silane C18 chemically bonded 
column (Waters XBridge, 4.6 x 150 mm, 5 μm). The mobile phase was a gradient of 
(0.5% acetic acid aqueous solution) (eluent A) with ACN ‘Acetonitrile’ (eluent B). The 
gradient elution was set for a liner gradient starting from 90% of eluent A and 10% 
eluent B up to 40% of eluent A and 60% of eluent B for 50 minutes. Before the analysis, 
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the column was equilibrated with the starting mobile phase for about 20 minutes. All the 
solvents and sample were filtered with a 0.45 m microporous filter and were degassed 
by sonication prior to use.  Wavelengths of 260 nm and 350 nm were chosen since it 
was found that the salvia palaestina compounds possess maximum absorption at these 
wavelengths. The flow rate was set at 1 ml/min. The injection volume was 10 l of 3 
mg/ml and the temperature of the column was room temperature. The HPLC preparative 
experiments were run on ODS column (Agilent PrepHT C18, 22.2 x 250 mm, 10 μm). 
 
The same mobile phase was used, and the gradient elution was set for a linear gradient 
starting from (90% of eluent A and 10% eluent B) up to (50% of eluent A and 50% 
eluent B) for 20 minutes and then the preparative HPLC system was washed for 10 min. 
with 90 % ACN to elute any lipophilic compounds from the column. The flow rate used 
was 15ml/min, the injection volume was 1000 µl and the temperature of the column was 
at room temperature.  
 
2.3.5.2 Sample preparation: 
 
The sample solution of crude salvia palaestina was prepared by dissolving about 75 
mg in 3 ml of 50% EtOH, shaken by mechanical means for 1 min, sonicated for two 
min. and then was filtered using 0.45 m membrane filter before injection. The 
obtained final solution contained 25 mg/ml. One ml of this solution was directly 
injected to the preparative HPLC and seven fractions were collected.  
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2.3.6 Evaporation of the fractions and lyophilization:  
 
The aliquots collected were dried by using rotary evaporator to remove the acetonitrile 
solvent followed by freeze drying to get rid of the water and ending up with few mg’s 
of fluffy powdered material. 
 
2.3.7  Testing  the fractions using the semi quantitative method:  
 
The fractions were dissolved in distilled water and sonicated for 10 min in order to be 
tested for its ability to inhibit β-hematin formation using Deharo semi-quantitative 
assay. See Section 2.3.4. 
 
2.3.8 In vitro Quantitative method: 
 
According to [Blauer and Akkawi, 1997], freshly prepared stock solution of hemin 
chloride was prepared by dissolving the salt in 0.4 N aqueous NaOH and incubated for 
30 min at 37 °C, stock solution of the leaf extract used was prepared using ultra-pure 
water. The final concentration of hemin and S.palaestina leaf crude ethanol extract 
were 0.5 and 1 mg/ml respectively, aqueous HCl was also included in order to obtain 
the required pH (ionic strength was 0.1235 M). The reaction was equilibrated at 37 °C 
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for 10 min, finally 4 µL of glacial acetic acid were added with gentle mixing [Blauer 
and Akkawi, 2000]. The whole mixture was left for 2 h at 37 °C without stirring. The 
total volume of the reaction mixture was 4 mL, and the final pH was 4.9 to 5.2. 
Samples were centrifuged for 10 min using (Jouan B4) centrifuge. The supernatant was 
discarded and the precipitate was washed with ultra-pure water and quantitatively 
transferred to a Millipore Swinnex 13 filter containing Whatman filter paper No. 50, 
already lyophilized to a constant weight in freeze-drying machine (Labconco 
Freezone). DMSO was passed slowly through the filter until the filtrate remained 
feebly colored and washed again with ultra-pure water. The remaining precipitate was 
then lyophilized to a constant weight [Blauer and Akkawi, 1997]. 
 
2.3.9 FTIR spectrum  
 
0.4 mg of each fraction was milled with 400 mg of potassium bromide (KBr) to form a 
very fine powder. This powder was then compressed for 4 min under 9 tons of pressure to 
form a thin pellet using Carver compressor. The pellet was then analyzed using thermo 
FTIR.  
FTIR measurement was taken against KBr disc as a background. 
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Chapter 3 
Results 
3.1 Semi Quantitative screening test results 
 
Results of experiments done according to E. Deharo semi-quantitative method on different 
plant extracts are shown below in Tables 3.1A, 3.1B, 3.2A and 3.2B. Tables 3.1A and 3.1B 
show results of two different tested herbal extracts Achillea Fragrantissima and Salvia 
palaestina, collected from rural areas around Jerusalem, while Tables 3.2A and 3.2B show the 
results of other two sea weeds tested, Ulva fascianta and Cladophora aegagropila. The 
efficiency of these   extracts in inhibiting β–hematin formation in vitro is compared to 
positive and negative controls. According to this semi-quantitative method, absorbance value 
measured at 405 nm is inversely proportional to drugs efficiency, the lower the absorption is, 
the drug is considered to be more efficient. 
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Table 3.1A:  The efficiency of herbal leafs 35% ethanol extracts of Achillea Fragrantissima 
and Salvia palaestina compared to the negative and positive controls, showing the 
absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm using 
ELISA reader, according to E. Deharo semi-quantitative method.  
 
 Negative controls Positive controls Herbal extract in 35% ethanol  
Test # Water 35% 
ethanol 
2-MP 
1mg/ml 
CQ 
0.1mg/ml 
Achillea 
Fragrantissima 
1mg/ml 
Salvia 
palaestina 
1mg/ml 
1 2.275 2.161 0.046 0.039       2.097 0.047 
2 2.371 2.186 0.049 0.041 1.711 0.05 
3 2.336 2.147 0.061 0.035 2.17 0.056 
4 2.08 2.061 0.04 0.041 2.099 0.043 
5 1.978 2.211 0.058 0.036 2.021 0.035 
6 1.994 2.231 0.033 0.043 1.592 0.059 
7 2.209 2.194 0.049 0.064 1.736 0.037 
8 2.143 2.169 0.033 0.052 1.82 0.04 
9 2.277 2.201 0.042 0.033 1.554 0.051 
10 2.339 2.151 0.067 0.043 2.112 0.055 
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Table 3.1B:  The efficiency of herbal leafs 35% ethanol extracts of Achillea Fragrantissima 
and Salvia palaestina compared to the negative and positive controls, showing the 
absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm using 
ELISA reader, according to E. Deharo semi-quantitative method. 
 
Test # Negative controls Positive controls Herbs 35% ethanol extract  
Water 35% 
ethanol 
2-MP 
1mg/ml 
CQ 
0.1mg/ml 
Achillea Fragrantissima 
1mg/ml 
Salvia palaestina 
1mg/ml 
1 2.215 2.271 0.076 0.039 2.112 0.037 
2 2.208 2.23 0.068 0.037 1.612 0.035 
3 2.052 2.281 0.056 0.040 1.789 0.042 
4 2.094 2.208 0.045 0.058 2.011 0.053 
5 2.291 2.174 0.057 0.060 1.599 0.051 
6 2.15 2.139 0.061 0.054 1.652 0.046 
7 2.222 2.109 0.079 0.038 1.784 0.032 
8 2.152 2.118 0.058 0.053 1.697 0.038 
9 2.263 2.306 0.05 0.041 1.595 0.037 
10 2.27 2.22 0.041 0.048 1.928 0.040 
 
Table 3.1 C below summarizes semi-quantitative results of Tables 3.1A and 3.1B showing the 
average and standard deviation values. These values are represented using column diagram in 
Figure 3. 
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Table 3.1C:  Average and standard deviation values for all absorption measurements at 405 
nm of both Tables 3.1A and 3.1B using Deharo semi quantitative method done on 
A. Fragrantissima and S. palaestina 35% ethanol leaf extract. 
 
 Negative controls Positive controls Herbs  35% ethanol extract 
  water  35% 
ethanol 
2-MP 
1mg/ml 
CQ. 
0.1mg/ml 
A. Fragrantissima 
1 mg/ml 
S. palaestina 
 1 mg/ml 
Average 2.21 2.18 0.054 0.045 1.85 0.048 
STDEV 0.113 0.06 0.013 0.009 0.210 0.008 
 
 
Figure 3.1: Column diagram representing the efficiency of herbal leaf’s ethanol extracts 
compared to the negative and positive controls, showing the absorption values of 
dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, according 
to E. Deharo semi-quantitative method. Each result represents the average of 20 
individual experiments.  
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Table 3.2A: The efficiency of sea weeds 35% ethanol extracts of Ulva fascianta and 
Cladophora aegagropila compared to the negative and positive controls, 
showing the absorption values of dissolved β-Hematin (alkaline hematin) at 405 
nm using ELISA reader, according to E. Deharo semi-quantitative method. 
 
Test # Negative controls Positive controls Sea-weed 35% ethanol extract  
Water 35% 
ethanol 
2-MP 
1mg/ml 
CQ. 
0.1mg/ml 
Ulva fascianta 
1mg/ml 
Cladophora 
aegagropila 
1mg/ml 
1 2.102 2.105 0.061 0.036 1.954 2.119 
2 2.238 2.142 0.08 0.044 2.151 2.173 
3 2.226 2.28 0.076 0.054 2.006 2.16 
4 2.22 2.223 0.064 0.059 1.991 2.118 
5 2.245 2.266 0.072 0.057 2.026 2.104 
6 2.34 2.267 0.051 0.071 2.269 2.258 
7 2.165 2.271 0.059 0.056 2.037 2.108 
8 1.922 2.163 0.042 0.055 2.093 2.238 
9 2.254 2.215 0.056 0.048 2.093 2.221 
10 2.306 2.044 0.045 0.05 2.239 2.162 
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Table 3.2B:  The efficiency of sea weeds 35% ethanol extracts of Ulva fascianta and 
Cladophora aegagropila compared to the negative and positive controls, showing 
the absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm using 
ELISA reader, according to E. Deharo semi-quantitative method.  
 
Test # Negative controls Positive controls Sea-weed 35% ethanol extract  
Water 35% 
ethanol 
2-MP 
1mg/ml 
CQ. 
0.1mg/ml 
Ulva fascianta 
1mg/ml 
Cladophora 
aegagropila 
1mg/ml 
1 2.275 2.01 0.068 0.039 2.175 2.216 
2 2.171 2.209 0.048 0.041 2.094 2.162 
3 2.236 2.075 0.045 0.035 2.029 1.979 
4 2.08 2.001 0.052 0.041 1.926 2.174 
5 1.977 1.933 0.055 0.036 2.152 2.026 
6 1.974 1.857 0.061 0.043 2.037 2.269 
7 2.011 2.16 0.069 0.064 1.974 2.157 
8 2.183 2.087 0.045 0.052 2.168 2.093 
9 2.277 1.963 0.057 0.059 2.041 2.187 
10 2.32 1.932 0.039 0.043 2.085 2.1661 
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Table 3.2C:  Average and standard deviation values for all absorption measurements at 405 
nm of both tables 4.2A and 4.2B using Deharo semi quantitative method done on 
Ulva fascianta and Cladophora aegagropila 35% ethanol leaf extract 
 
 Negative controls Positive controls Sea-weed 35% ethanol extract  
Water 35% 
ethanol 
2-MP 
1mg/ml 
CQ. 
0.1mg/ml 
Ulva fascianta 
1mg/ml 
Cladophora 
aegagropila 
1mg/ml 
Average 2.172 2.110 0.057 0.049 2.077 2.155 
STDEV 0.116 0.130 0.012 0.010 0.093 0.072 
 
 
Figure 3.2: Column diagram representing the efficiency of different sea weeds extracts 
compared to the negative and positive controls, showing the absorption values of 
dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, according 
to E. Deharo semi-quantitative method.  
Different extracts of S. palaestina leaf were prepared using different solvents (water and 35% 
ethanol) and semi-quantitative test results are shown in Tables 3.3A.  
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Table 3.3A: The efficiency of Salvia palaestina leaf different extracts compared to the 
negative and positive controls, showing the absorption values of dissolved β-
Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. 
Deharo semi-quantitative. 
 
Test # Negative control Positive control Salvia in 
35% ethanol 
Salvia in 
water 
Water DMSO CQ. 
0.1mg/ml 
AQ. 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 1mg/ml 
1 2.341 1.867 0.052 0.074 0.069 0.061 0.089 
2 2.374 1.859 0.065 0.075 0.038 0.043 0.122 
3 2.300 1.784 0.076 0.070 0.049 0.040 0.115 
4 2.209 1.78 0.061 0.072 0.036 0.050 0.089 
5 2.310 1.935 0.043 0.078 0.037 0.049 0.130 
6 2.300 1.853 0.035 0.045 0.046 0.059 0.086 
7 2.204 1.933 0.080 0.035 0.064 0.054 0.093 
8 2.261 1.857 0.065 0.149 0.050 0.049 0.101 
9 2.266 1.961 0.042 0.049 0.068 0.053 0.091 
10 2.275 1.907 0.076 0.080 0.039 0.052 0.086 
11 2.385 1.963 0.082 0.078 0.051 0.042 0.099 
12 2.257 1.932 0.049 0.059 0.035 0.064 0.112 
13 2.293 2.001 0.038 0.045 0.064 0.040 0.085 
14 2.358 1.954 0.046 0.038 0.045 0.063 0.110 
15 2.282 2.010 0.057 0.068 0.035 0.043 0.086 
16 2.303 1.887 0.048 0.108 0.040 0.039 0.080 
17 1.894 1.987 0.058 0.022 0.058 0.048 0.126 
18 1.990 1.991 0.040 0.038 0.046 0.058 0.103 
19 2.126 1.892 0.069 0.048 0.068 0.053 0.093 
20 1.919 1.857 0.060 0.026 0.056 0.055 0.113 
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Table 3.3B: The average and standard deviation for Table 3.3A. Concerning the absorption 
measurements of dissolved β-Hematin at 405 nm using Deharo semi-quantitative 
method done on S. palaestina different extracts. 
 
 Negative control Positive control salvia in  35% 
ethanol 
Salvia in 
water 
Water DMSO CQ. 
0.1mg/ml 
AQ. 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 1mg/ml 
Average 
Abs. at 
405nm 2.232 1.911 0.057 0.063 
 
0.05 
0.050 0.100 
STDEV 0.142 0.067 0.015 0.030 0.012 0.008 0.015 
 
Figure 3.3 below shows the efficiency of two different extracts of salvia palaestina leaf in 
inhibiting β-hematin formation according to E. Deharo semi-quantitative method, compared 
to positive and negative controls, lower values indicates higher efficiency. 
 
 
Figure 3.3: Column diagram representing the efficiency of two different salvia palaestina leaf 
extracts using 35% ethanol and water, both at 1mg/ml, compared to the negative 
and positive controls, showing the absorption values of dissolved β-Hematin 
(alkaline hematin) at 405 nm using ELISA reader, according to E. Deharo semi-
quantitative method.   
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Tables 3.4A, 3.4B, 3.5A and 3.5B show the efficiency of the Salvia palaestina leaf aqueous 
and 35% ethanol extract respectively, several dilutions were made in order to determine the 
lowest concentration that can inhibit β-hematin crystallization compared to the negative and 
positive controls, showing the absorption values of dissolved β-Hematin (alkaline hematin) at 
405 nm using ELISA reader, according to E. Deharo semi-quantitative. 
Table 3.4A: The efficiency of Salvia palaestina leaf aqueous extract compared to the negative 
and positive controls, showing the absorption values of dissolved β-Hematin 
(alkaline hematin) at 405 nm using ELISA reader, according to E. Deharo semi-
quantitative. 
 
 Negative controls Positive controls crude extract of S. palaestina in 
water 
Test # Water 35% 
ethanol 
CQ 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 
1 2.140 2.220 0.073 0.062 0.099 0.209 
2 2.050 1.927 0.046 0.054 0.112 0.251 
3 2.100 2.210 0.044 0.060 0.085 0.232 
4 2.137 2.005 0.031 0.042 0.110 0.267 
5 2.150 2.230 0.032 0.041 0.086 0.302 
6 2.113 2.186 0.042 0.039 0.080 0.322 
7 2.158 1.936 0.045 0.048 0.126 0.243 
8 2.010 2.167 0.041 0.045 0.103 0.331 
9 2.040 2.161 0.059 0.049 0.093 0.299 
10 2.107 2.126 0.050 0.046 0.113 0.319 
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Table 3.4B: The efficiency of Salvia palaestina leaf aqueous extract compared to the negative 
and positive controls, showing the absorption values of dissolved β-Hematin 
(alkaline hematin) at 405 nm using ELISA reader, according to E. Deharo semi-
quantitative method. 
 
Test # Negative controls Positive controls crude extract of S. palaestina in 
water 
Water 35% 
ethanol 
CQ 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 
1 2.025 2.147 0.055 0.054 0.089 0.256 
2 2.068 1.891 0.039 0.052 0.122 0.182 
3 1.983 2.241 0.057 0.061 0.115 0.197 
4 2.029 2.126 0.04 0.068 0.089 0.239 
5 2.122 2.032 0.033 0.057 0.130 0.293 
6 2.131 2.098 0.043 0.048 0.086 0.301 
7 2.198 1.997 0.055 0.07 0.093 0.291 
8 2.263 1.958 0.046 0.067 0.101 0.199 
9 2.101 2.147 0.062 0.047 0.091 0.324 
10 2.164 2.011 0.037 0.059 0.086 0.261 
 
Table 3.4C:  Average and standard deviation values for all absorption measurements at 405 
nm of both tables 3.4A and 3.4B using Deharo semi quantitative method, done on 
S. palaestina aqueous extract.    
 Negative 
control 
Positive controls crude extract of S. 
palaestina in water 
water  
35% 
ethanol 
CQ 
0.1mg/ml 
2-MP 
1mg/ml 1mg/ml 0.5mg/ml 
Average 
Abs. at 
405nm 2.1 2.091 0.047 0.053 0.100 0.266 
STD 
deviation 0.069 0.11 0.011 0.009 0.015 0.046 
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Figure 3.4: Column diagram representing the efficiency of S. palaestina leaf aqueous extract 
compared to the negative and positive controls, showing the absorption values of 
dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, according 
to E. Deharo semi-quantitative method. Each result represents the average of 20 
individual experiments. 
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Table 3.5A: The efficiency of 35% ethanol extract of Salvia palaestina leaf compared to the 
negative and positive controls, showing the absorption values of dissolved β-
Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. 
Deharo semi-quantitative. 
 
 Negative control Positive controls Crude leaf extract of S. palaestine in 35% EtOH 
Test # 
 
Water CQ. 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 0.3mg/ml 0.1mg/ml 
1 2.296 0.058 0.085 0.044 0.044 0.166 2.093 
2 2.325 0.050 0.063 0.038 0.050 0.087 2.068 
3 2.259 0.044 0.102 0.035 0.045 0.105 1.915 
4 2.280 0.047 0.074 0.039 0.048 0.106 2.002 
5 2.279 0.058 0.063 0.037 0.040 0.102 2.038 
6 2.289 0.057 0.060 0.034 0.045 0.118 2.030 
7 2.244 0.054 0.059 0.037 0.052 0.115 2.086 
8 2.325 0.050 0.071 0.045 0.041 0.136 2.027 
9 2.301 0.040 0.098 0.038 0.053 0.167 2.051 
10 2.347 0.053 0.108 0.053 0.046 0.123 2.030 
11 2.140 0.062 0.058 0.041 0.064 0.136 2.069 
12 2.110 0.045 0.073 0.055 0.060 0.151 2.118 
13 1.978 0.042 0.059 0.050 0.043 0.173 2.123 
14 2.061 0.044 0.052 0.039 0.063 0.184 2.184 
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Table 3.5B: The efficiency of 35% ethanol extract of Salvia palaestina leaf compared to the 
negative and positive controls, showing the absorption values of dissolved β-
Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. 
Deharo semi-quantitative method. 
 
 Negative control Positive controls Crude extract of S. palaestine in 35% EtOH 
Test # 
 
Water CQ. 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 0.3mg/ml 0.1mg/ml 
1 2.377 0.048 0.045 0.038 0.049 0.123 1.992 
2 2.400 0.038 0.052 0.038 0.049 0.156 1.941 
3 2.338 0.036 0.055 0.042 0.054 0.090 1.975 
4 2.335 0.041 0.061 0.053 0.058 0.091 1.936 
5 2.374 0.046 0.059 0.051 0.045 0.190 1.970 
6 2.389 0.036 0.045 0.046 0.049 0.181 2.089 
7 2.094 0.05 0.037 0.032 0.051 0.195 2.009 
8 2.104 0.049 0.039 0.038 0.062 0.163 1.933 
9 2.145 0.063 0.095 0.037 0.045 0.100 2.049 
10 2.176 0.059 0.073 0.036 0.045 0.119 2.084 
11 2.155 0.063 0.088 0.037 0.048 0.114 2.015 
12 2.181 0.046 0.089 0.035 0.052 0.116 2.077 
13 2.121 0.044 0.074 0.033 0.060 0.204 2.008 
14 2.197 0.043 0.066 0.040 0.050 0.198 2.054 
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Table 3.5C: The average and standard deviation for both tables 3.5A and 3.5B.  Regarding 
the absorption measurements of dissolved β-Hematin at 405 nm using Deharo 
semi quantitative method done on S. palaestina 35% crude extract dissolved in 
distilled water. 
 
 Negative control Positive controls S. palaestine 35 % crude extract 
water CQ 
0.1mg/ml 
2-MP 
1mg/m
l 
1mg/ml 0.5mg/ml 0.3mg/ml 0.1mg/ml 
Average Abs. 
at 405nm 
2.24 0.049 0.067 0.041 0.05 0.139 2.03 
STD deviation 0.113 0.008 0.02 0.006 0.007 0.037 0.063 
 
 
Figure 3.5: Column diagram representing the efficiency of S. palaestina leaf 35% ethanol 
extract compared to the negative and positive controls, showing the absorption 
values of dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, 
according to E. Deharo semi-quantitative method. Each result represents the 
average of 28 individual experiments. 
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Table 3.6 below summarizes the results obtained testing the efficiency of S. palaestina stem 
extract in 35% ethanol in inhibiting β-hematin formation in vitro. 
 
 
Table 3.6A:  The efficiency of 35% ethanol extract of Salvia palaestina Stem compared to the 
negative and positive controls, showing the absorption values of dissolved β-
Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. 
Deharo semi-quantitative method. 
 
 Negative control Positive control Salvia stem 35% EtOH extract 
Test # Water CQ 
0.1mg/m
l 
2-MP 
1mg/ml 
1mg/m
l 
0.5mg/ml 0.3mg/ml 0.1mg/ml 
1 2.304 0.052 0.061 0.152 0.206 1.311 2.167 
2 2.254 0.043 0.053 0.121 0.09 1.404 2.247 
3 2.112 0.031 0.064 0.064 0.151 1.399 2.182 
4 2.310 0.066 0.046 0.07 0.124 1.432 2.184 
5 2.264 0.028 0.042 0.091 0.116 1.221 2.289 
6 2.186 0.033 0.055 0.109 0.146 1.549 2.206 
7 1.989 0.051 0.067 0.069 0.138 1.274 2.058 
8 2.045 0.035 0.071 0.055 0.183 1.66 2.107 
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Table 3.6B: The efficiency of 35% ethanol extract of Salvia palaestina Stem compared to the 
negative and positive controls, showing the absorption values of dissolved β-
Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. 
Deharo semi-quantitative method. 
 
 
 Negative 
control 
Positive control Salvia stem 35% EtOH extract 
Test # water CQ 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 0.3mg/ml 0.1mg/ml 
1 2.200 0.050 0.076 0.13 0.15 1.509 2.215 
2 2.135 0.064 0.059 0.082 0.26 1.638 2.208 
3 2.175 0.054 0.046 0.107 0.206 1.242 2.228 
4 2.057 0.053 0.061 0.125 0.173 1.549 2.164 
5 2.065 0.038 0.050 0.062 0.124 1.406 2.273 
6 2.110 0.062 0.055 0.079 0.118 1.428 1.924 
7 2.154 0.043 0.048 0.121 0.185 1.389 2.005 
8 2.026 0.044 0.042 0.061 0.203 1.501 1.968 
 
Table 3.6C: The average and standard deviation for both tables 3.6A and 3.6B.  Regarding 
the absorption measurements of dissolved β-Hematin at 405 nm using Deharo 
semi quantitative method done on S. palaestina stem 35% crude extract dissolved 
in distilled water. 
 
 Negative 
control 
Positive control Salvia stem 35% EtOH extract 
 water CQ 
0.1mg/ml 
2-MP 
1mg/ml 
1mg/ml 0.5mg/ml 0.3mg/ml 0.1mg/ml 
Average 2.149 0.047 0.056 0.094 0.161 1.430 2.151 
STDEV 0.100 0.0118 0.010 0.030 0.044 0.131 0.110 
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Figure 3.6: Column diagram representing the efficiency of S. palaestina Stem 35% ethanol 
extract compared to the negative and positive controls, showing the absorption 
values of dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, 
according to E. Deharo semi-quantitative method. Each result represents the 
average of 16 individual experiments. 
 
Table 3.7 below shows the semi quantitative test results according to E. Deharo method, done 
for Camphor a chemical constituent in S. palaestina extract, showing the absorption values of 
dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, semi-quantitative 
method. 
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Table 3.7: The efficiency of camphore compared to the negative and positive controls, 
showing the absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm 
using ELISA reader, according to E. Deharo semi-quantitative method. 
 
 Negative controls Positive controls Tested  chemical 
Test # Water DMSO CQ. 
0.1mg/m 
AQ. 
0.1mg/ml 
2-MP. 
1mg/ml 
Camphor 
1mg/ml 
1 2.076 2.075 0.059 0.086 0.036 2.050 
2 2.182 2.130 0.042 0.100 0.049 2.049 
3 1.918 2.157 0.051 0.060 0.061 2.239 
4 1.917 2.094 0.060 0.102 0.040 1.779 
5 2.102 2.138 0.072 0.140 0.058 2.210 
6 2.226 2.101 0.065 0.096 0.033 1.907 
7 2.021 2.171 0.055 0.520 0.046 2.143 
8 2.149 2.101 0.049 0.130 0.033 1.823 
9 1.975 2.018 0.062 0.072 0.045 1.878 
10 2.008 1.994 0.058 0.064 0.052 2.065 
Average 2.057 2.098 0.057 0.370 0.045 2.014 
STDEV 0.110 0.057 0.009 0.140 0.010 0.160 
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3.2 Preparative-HPLC-PDA separation of the active antimalarial fractions from crude 
Salvia palaestina: 
 
A total of fourteen compounds were separated using analytical RP-HPLC at 265 nm (Figure 
3.7 A, B). The overlaid UV spectra of the eluted peaks are shown in Figure 3.8. 
 
 
 
Figure 3.7A: Typical analytical HPLC chromatogram of 35% ethanolic crude mixture of 
salvia palaestina.  10 µl were injected at flow rate 1 ml/min and monitoring λ at 
260 nm.  
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Figure 3.7B: shows the same chromatogram as in Figure 3.7A, but zoomed, at 350 nm. 
The HPLC chromatogram revealed the following percentages of each eluted compounds at 
350 nm shown in Table 3.8.  
Table 3.8: The percentages of each eluted compounds at 350 nm revealed from HPLC 
chromatogram. 
Peak tR (mins) % Area 
5.273 0.68 
7.224 1.74 
9.255 2.70 
11.443 2.79 
11.993 42.12 
12.848 9.81 
13.152 4.25 
13.849 2.76 
14.254 1.57 
14.795 7.52 
15.147 3.72 
15.611 13.32 
15.916 6.30 
18.113 0.71 
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Figure 3.8: Overlaid UV spectra of the eluted peaks in Figure 3.7A. 
 
Further step of purification on the 35% ethanol crude extract of salvia palaestina was attained 
by loading 1000 µl (25mg/ml) to the preparative column and eluted subsequently using 
gradient binary solvent mixture of acidic water and ACN.  Eight major fractions (I-VIII) with 
different concentrations were obtained as shown in Figure 3.8. 
 
Only three fractions were found to exhibit anti-malarial activity when tested in-vitro. We 
noticed that the most pharmacological potent fraction is fraction VII which was eluted 
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between 14.8-19 min as shown in Figure 3.9.  To acquire the active fractions in high quantity, 
other preparative injections were successively made and three major fractions were 
recollected..accordingly. 
 
 
 
Figure 3.9: Typical preparative HPLC chromatogram of 35% ethanol crude mixture of salvia 
palaestina.  1000 µl were injected at flow rate 15 ml/min and the monitoring λ of 
260 nm was used. Fraction I was collected from (2-3.2 minutes), fraction II (3.3-7 
minutes), fraction III (7-9.6 minutes), fraction IV (9.6-12.1 minutes), fraction V 
(12.2-13 minutes), fraction VI (13-14.8 minutes) and fraction VII (14.8-19 
minutes). 
 
3.3 Salvia fractions semi-quantitative test results 
Table 3.9 below shows the results of semi-quantitative method done according E. Deharo on 
the fractions obtained after separation of S. palaestina 35% EtOH crude extract, the efficiency 
of these extracts in inhibiting β–hematin formation in vitro is compared to positive and 
negative.controls.
   
54 
 
Table 3.9: The efficiency of S. palaestina 35% ethanol extract fractions compared to the negative and positive controls, showing 
the absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm using ELISA reader, according to E. Deharo 
semi-quantitative. 
 
Negative 
control 
Positive control 
Fractions obtained from S. palaestina 35% EtOH extract, all at 
concentration 0.5mg/ml 
Test # water 
CQ 
0.1mg/ml 
MP 
1mg/ml 
F. I F. II F. III F. IV F. V F. VI 
F. 
VII 
F. VIII 
1 2.045 0.044 0.032 1.785 1.954 0.289 0.322 0.086 0.058 0.071 1.281 
2 2.062 0.047 0.035 1.995 2.007 0.3 0.211 0.157 0.065 0.089 1.184 
3 2.065 0.039 0.064 1.86 1.928 0.181 0.19 0.067 0.075 0.062 0.856 
4 2.153 0.054 0.045 1.873 1.768 0.383 0.25 0.108 0.082 0.058 0.819 
5 2.144 0.04 0.052 1.924 1.823 0.191 0.256 0.072 0.099 0.048 0.758 
6 1.98 0.061 0.027 1.838 2.056 0.304 0.312 0.094 0.062 0.052 0.971 
Average 2.075 0.0475 0.043 1.879 1.923 0.275 0.257 0.097 0.074 0.063 0.978 
STDEV 0.065 0.009 0.014 0.073 0.109 0.076 0.053 0.033 0.015 0.015 0.211 
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Figure 3.10: Column diagram representing the efficiency of the eight fractions obtained from 
separation of S. palaestina leaf 35% ethanol extract, dissolved in water at 
concentration 0.5mg/ml, compared to the negative and positive controls, 
showing the absorption values of dissolved β-Hematin (alkaline hematin) at 405 
nm using ELISA reader, according to E. Deharo semi-quantitative method. Each 
result represents the average of 6 individual experiments. 
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Figure 3.11: Column diagram representing the efficiency of combinations made of the 
fractions obtained from separation of S. palaestina leaf 35% ethanol extract, 
dissolved in water, compared to the negative and positive controls, showing the 
absorption values of dissolved β-Hematin (alkaline hematin) at 405 nm using 
ELISA reader, according to E. Deharo semi-quantitative method. Each result 
represents the average of 5 individual experiments. 
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3.4 Quantitative test results: 
 
Figure 3.12: Column diagram representing the percentage yields of salvia leaf 35% ethanol 
extract as potential anti-malarial drug, compared to CQ and water. Yields are 
inversely proportional to drugs efficiency, the lower the yield is, the drug is 
considered to be more efficient. 
 
Figure 3.13: Column diagram representing the efficiencies of salvia leaf 35% ethanol extract 
as potential anti-malarial drug compared to CQ and water. 
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Chapter 4 
Discussion and Conclusion 
 
4.1 Discussion 
 
During the erythrocytic stage, massive degradation of hemoglobin generates large amounts of 
heme which is toxic to the parasite. Malaria parasite, nevertheless, has evolved a distinct 
mechanism for detoxification of heme through its conversion into an insoluble crystalline 
pigment, known as hemozoin. Hemozoin synthesis is an indispensable process for the parasite 
survival and is the target for action of numerous anti-malarials. Quinoline anti-malarials have 
been found to be the most consistent inhibitors of hemozoin synthesis. [Sullivan et al., 1996; 
1998].  
 
As strains of the malaria parasite Plasmodium emerged gaining resistant to these drugs used, 
the search for new anti-malarial drugs has become a must. Hemozoin detoxification pathway 
has, therefore, attracted significant interest for new anti-malarial drug discovery research, and 
is the topic of this work. A synthetic polymer structure made from Ferriprotoporphyrin (IX) 
named β-Hematin is believed to be structurally, chemically and spectroscopically identical to 
purified hemozoin, making it an outstanding alternative for in vitro studies [Slater et. al., 
1991; Blauer and Akkawi, 1997, 2000; Pagola et. al., 2000].  
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In this research the potential inhibitory effect of different herbs and sea weed extracts on β-
hematin (synthetic Hemozoin) formation was studied in vitro using a simple screening semi-
quantitative method followed by a more analytical quantitative method. 
A concentration of 1mg/ml of the potential drug was used in these screening tests, while the 
concentration of hemin chloride in all of these tests was 0.5 mg/ml. Only the alcoholic 
extracts of Salvia palaestina leaves showed promising results when compared to other plant 
extracts like Achillea Fragrantissima, Ulva fascianta and Cladophora aegagropila using the 
same positive and negative controls, as seen in Tables 3.1A/B and 3.2A/B, and Figures 3.1 
and 3.2. 
 
CQ and AQ are two universally known anti-malarial drugs that are used extensively in the 
fight against malaria, known to inhibit the process of β-hematin crystallization, were used as 
positive controls. (Mercaptopyrimidine “2-MP”), another positive control that was used as 
internal control was found to be highly sensitive to minor changes in the test conditions, 
especially temperature and thus is a good index of the test accuracy that has been used to 
confirm or rule out the results. Water, ethanol or DMSO were used as negative controls. 
According to this semi-quantitative screening method, each absorption value is inversely 
proportional to the efficiency of the extract to inhibit β-hematin formation; low absorption 
indicates higher efficiency and vice versa.  
 
Natural compounds were used throughout as drugs. Sage is distinguished by its astonishing 
versatility, and considered as one of the oldest medicinal plants. We chose sage as it is known 
to be used against many diseases, due to the fact that salvia species are very rich in 
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biologically active compounds. Some researchers suggested that sage could have anti-malarial 
drugs [Dixon et al., 2013].  
 
Not only the alcoholic leaf or stem extracts (35% ethanol) have anti-malarial activity, but also 
the aqueous leaf extract has considerable activity to prevent β-hematin polymerization. This 
inhibitory effect of the crude may be due to the fact that all of them contain polyphenols and 
thujone as evidenced by [Mokcute et al., 2003; Gürsoy et al., 2012]. Nevertheless, the most 
distinctive effect was that of S. palaestina leaf extract in 35% ethanol. 
 
 “Hydroalcoholic mixtures of ethanol are possibly the most suitable solvent system for the 
extraction of sage polyphenols due to the different polarities of the bioactive constituents, and 
the acceptability of this solvent system for human consumption” [Dent et al., 2013], also 
aqueous sage extract does contain polyphenols [Walch et al., 2011]. 
 
Polyphenols are known to be anti-oxidants, considerable interest was given to these 
compounds recently because of their potential beneficial effects on human health in fighting 
diseases such as cancer and cardiovascular disease [Scalbert et al., 2005; Shohaib et al., 
2011], and the most common types of polyphenols are flavonoids. 
 
The mechanism of action of these plant extracts as anti-malarials is thought to be by inhibition 
of β-hematin formation which is probably through formation of a complex between the active 
compounds in these extracts and ferri-heme. Different non-covalent interactions may be 
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responsible for this inhibition. For example we can talk about the possibility of forming 
hydrogen bonding between propionic acid in ferri-heme and the active compounds in the 
extract, containing a carbonyl group as an example, can terminate β-hematin extension, see 
Figure 4.1 below, this may explain the inhibitory effect of the crude extract and HPLC 
fractions on the formation of synthetic Hemozoin. 
 
In the case of the crude extract, the inhibitory effect may be due to at least to the presence of 
different chemical constituents in the extracts, such as different polyphenols and thujone. 
Thujone is the main constituent of sage essential oil, which may bind to the free hemin and 
thus prevents β-hematin extension.  
 
Figure 4.1: The dimer of Fe (III) PPIX observed in the β-hematin DMSO solvate structure. 
The hydrogen bond (O3−H3···O6) between the propionic acid group of Fe (III) 
PPIX and an included DMSO molecule is indicated as a dashed red line. Atom 
colors are: gray, C; white, H; blue, N; red, O; cyan, Fe; and yellow, S. 
[Gildenhuys et al., 2012] 
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The basic structural of flavonoid compounds is three rings; two aromatic rings linked by a 
three-carbon bridge [C6-C3-C6] [Pedro et al., 2012]; Apigenin and Luteolin are good 
examples of flavonoids. 
 
Luteolin (see Figure 4.2) is widely distributed in many types of plants including fruits, 
vegetables, and medicinal herbs. Its anti-cancer activity has been reviewed by [Seelinger et 
al., 2008]. 
 
The effect of different flavonoids on the growth of Plasmodium falciparum has been studied 
by [Lehane and saliba, 2008]; luteolin was found to be the most active with IC50 values 
around 11 µM. The flavonoid luteolin is found in Artemisia species [Brown G., 2010; Seddik 
et al., 2010] presenting an anti-malarial activity; luteolin is also present in salvia species 
according to [Đorđević et al., 2000]. Another study showed that when luteolin is administered 
to rodents in high doses it has no toxic effect [Mukinda J., 2005]. 
 
 
Figure 4.2: The structure of luteolin. 
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It is known that flavonoids chelate metals such as iron and copper as part of their antioxidant 
effects and that iron chelating therapies have been recommended for malaria patients.  
 
The essential oil composition of Salvia showed the dominance of monoterpenes and 
sesquiterpenes, like thujone, 1,8-cineole and camphor [Gürsoy et al., 2012]. One of these, 
camphor, was tested using the semi-quantitative method and was found to have no effect on 
beta hematin polymerization as shown in Table 3.7.  
 
Thujone is a ketone and a monoterpene, found in many different plants including sage, as well 
as many other herbs and spices. Thujone occurs naturally in two diastereomeric forms: α-
thujone and β-thujone see Figure 4.3. Thujone is considered potential anti-malarial agent 
according to [Ramazani et al., 2010]. It is also present in Artimisia species [Abad et al., 2012], 
that are used to treat malaria. 
 
Figure 4.3: The structure of α and β-thujone. 
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Evidence that thujone is the active anti-malarial molecule in many artemisia species is 
confirmed by the fact that Artemisia dracunculus which contains no thujone has no noticeable 
antimalarial activity [Lutgen, 2012]. Many recent studies also found that the anti-cancer 
properties of several plants, including Artemisia absinthium, are proportional to the 
concentration of thujone [Biswas et al., 2011;  Russo et al., 2013]. Other plants like sage 
contain large amounts of thujone and for that are considered as potential anti-malarial drugs.   
 
Quantitative test done on the crude alcohol extract confirmed the previous results obtained 
with efficiency 71.1% when compared to CQ 93% water 11%, see Figures 3.12 and 2.13.  
 
Differences in the efficiency of leaf and stem ethanol extracts may be attributed to the fact 
that the amount of thujone present in the leaf is double that in the stem [Velickovi et al.,2003]. 
 
High performance liquid chromatography (HPLC) is the best technique to separate phenolic 
and triterpenoid compounds. Only three fractions (V, VI and VII) out of the eight fractions 
obtained using the preparative HPLC were found to exhibit anti-malarial activity when 
assayed in-vitro.   
 
We noticed that the most pharmacological potent fraction is fraction VII which was eluted 
between 14.8-19 minutes.  As shown in Figure 3.9, this fraction contains a major peak at 15 
minutes and to a lesser extent another few peaks that lack chromophore which strengthens our 
believe that this compound is the one responsible for anti-malarial activity.  Previous studies 
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on other salvia leaves species have proved the presence of phenolic compounds which possess 
strong UV absorption. [Lu and Foo, 2002]. 
 
Different combinations of the HPLC fractions obtained were tested using the semi-
quantitative method, to study if there is any synergistic effect of these random combinations, 
as shown in Figure 3.11. Any combination that contains one of the three active fractions 
enhanced the inhibitory effect on β-hematin formation, as shown in Table 4.1. For example a 
combination between fraction II and VI, showed increased effectiveness in inhibiting β-
hematin formation when compared to the calculated values. Experimental evidence suggests 
that some flavonoids may enhance the action of artemisinin against P. falciparum [Ferreira et 
al., 2010]. This also can be seen in other combinations as seen in the Table 4.1 below. 
 
Table 4.1: Result of different HPLC fraction combinations tests compared to the average 
calculated value of β-hematin dissolved in (0.1N) NaOH absorption at 405 nm. 
 
Fractions 
Combination 
Theoretical 
value 
Experimental 
value 
1+2 1.901 1.820 
1+3 1.077 1.480 
2+6 0.999 0.410 
5+7 0.080 0.190 
7+8 0.521 0.210 
6+8 0.526 0.230 
6+7 0.069 0.114 
2+3+7 0.748 0.620 
1+5+8 0.985 0.480 
1+2+3 1.359 1.350 
5+6+7 0.078 0.130 
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The identity of the active compound responsible for anti-malarial activity of S. palaestina 
ethanol extract noted is not determined in this study. However, such determination requires 
further studies using elemental analysis, Nuclear magnetic resonance NMR and Gas 
chromatography–mass spectrometry GC-MS. But the quantity of the fractions left after we 
finished the experiments was not enough to do all these identification tests. Currently we are 
planning to repeat the extraction in order to identify the active compounds. 
 
What we have done in this regard is FTIR measurement of the fractions. Although, FTIR 
measurement alone can’t be used to identify the active ingredient, the FTIR absorption of the 
HPLC fractions were measured, see Appendix. 
 
The FTIR spectral analysis of the ethanolic extract’s revealed bands in the region between 
1500 – 500 cm-1. Absorption bands at 3360 cm-1  is due to OH stretching , while 1654.98 - 
1525.74 cm
-1
 on the other hand is due to either C = C or C = O stretching. The intensive band 
at 1606  cm
-1
 is most probably the result of vibrations of C=O group. 
 
This is in correlation with the functional groups constituting flavonoids in the extract, which 
basically have C = O, C-OH as contributing functional groups and are correlated in the 
spectral peaks. 
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4.2 Conclusions 
 
In conclusion malaria is one of the oldest diseases known to man and considered as a global 
health problem. It is stoppable, yet more than 600,000 people die of it every year, due to the 
rise of resistant strains of Plasmodium, there is an urgent need to find new cheap and easily 
available anti-malarial drugs preferably from natural products. 
Salvia palaestina a safe and widely available herb, this herb has many traditional uses in the 
folk medicine. The extract is a natural product and has been used in folk medicine with no 
reported toxicity. It is clear from our work that sage is an inhibitor of β-Hematin formation, 
both as a crude extract and HPLC fractions, and hence must be given further attention as a 
possible antimalarial drug and in vivo tests must be done to study the antimalarial activity of 
this plant.  
 
Further Nuclear magnetic resonance NMR and Gas chromatography–mass spectrometry GC-
MS ought to be done to identify the active compound(s). 
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Appendix 
 
 
 
 
 
Figure 1:  Overlaid preparative HPLC chromatograms of 35% ethanol crude mixture of 
salvia palaestina.  1000 µl were injected for each at flow rate 15 ml/min and the 
monitoring λ of 260 nm was used
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Figure 4: FTIR spectrum of salvia palaestina 35% ethanol extract crude. 
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Figure 3: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction I. 
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Figure 4: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction II. 
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Figure 5: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction III. 
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Figure 6: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction IV. 
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Figure 7: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction V. 
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Figure 8: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction VI. 
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Figure 9: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction VII. 
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Figure 10: FTIR spectrum of salvia palaestina 35% ethanol extract Fraction VIII. 
 
